According to the new research report published by Precedence Research, titled “Computer-Aided Drug Discovery Market (By Type: Structure-based Drug Design, Ligand-based Drug Design, Sequence-based Approaches; By Therapeutic Area: Oncology, Neurology, Cardiovascular diseases, Respiratory diseases, Diabetes; By End User: Pharmaceuticals companies, Biotechnology companies, Research Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global computer-aided drug discovery market size is expected to be worth around US$ 10.44 billion by 2032 and is poised to record a yearly growth rate of 12% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on computer-aided drug discovery market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall computer-aided drug discovery market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2965
The study also provides important advancements in organic and inorganic growth strategies in the worldwide computer-aided drug discovery market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of computer-aided drug discovery market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Computer-Aided Drug Discovery Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 3.76 Billion |
| Market Size by 2032 | USD 10.44 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 12% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Type, By Therapeutic Area, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Prostate Cancer Market Size US$ 28.37 Billion by 2032
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the computer-aided drug discovery market.
Some of the prominent players in the computer-aided drug discovery market include
- Albany Molecular Research Inc. (AMRI)
- BOCSCI Inc.
- AstraZeneca
- Bioduro-Sundia
- Schrödinger, Inc.
- Bayer AG
- Aragen Life Sciences Pvt. Ltd.
- Charles River Laboratories
- Aris Pharmaceuticals
- Albany Molecular Research Inc.
Computer-Aided Drug Discovery Market Segmentations
By Type
- Structure-based Drug Design
- Ligand-based Drug Design
- Sequence-based Approaches
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular diseases
- Respiratory diseases
- Diabetes
By End User
- Pharmaceuticals companies
- Biotechnology companies
- Research Laboratories
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Report Objectives
- To define, segment, and project the global market size for computer-aided drug discovery market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Computer-Aided Drug Discovery Market
5.1. COVID-19 Landscape: Computer-Aided Drug Discovery Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Computer-Aided Drug Discovery Market, By Type
8.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Type, 2023-2032
8.1.1 Structure-based Drug Design
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Ligand-based Drug Design
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Sequence-based Approaches
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Computer-Aided Drug Discovery Market, By Therapeutic Area
9.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Therapeutic Area, 2023-2032
9.1.1. Oncology
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Neurology
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Cardiovascular diseases
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
9.1.4. Respiratory diseases
9.1.4.1. Market Revenue and Volume Forecast (2020-2032)
9.1.5. Diabetes
9.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Computer-Aided Drug Discovery Market, By End User
10.1. Computer-Aided Drug Discovery Market Revenue and Volume, by March, 2023-2032
10.1.1. Pharmaceuticals companies
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Biotechnology companies
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Research Laboratories
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Computer-Aided Drug Discovery Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.1.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.1.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.2.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.2.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.3.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.3.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.4.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.4.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
11.5.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)
11.5.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)
Chapter 12. Company Profiles
12.1. Albany Molecular Research Inc. (AMRI)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BOCSCI Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AstraZeneca
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bioduro-Sundia
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Schrödinger, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bayer AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Aragen Life Sciences Pvt. Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Charles River Laboratories
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Aris Pharmaceuticals
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Albany Molecular Research Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global computer-aided drug discovery market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for computer-aided drug discovery are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
